For example, some well known treatments for chronic pain from Lyme disease have been shown to have little usefulness, wrote Phillip J. Baker, PhD, executive director of the American Lyme Disease Foundation.
Further, unapproved and undocumented treatments are usually not covered by health insurance, forcing a significant financial burden on the patient.
Related Articles on Treating Chronic Pain:
Findings on Chronic Pain Gene May Lead to New Drugs
Evidence Found on how Meditation Relieves Pain
FDA Approves Lupin’s Generic Equivalent of Ultram ER for Chronic Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.